New insights to atopic dermatitis (atopic eczema)

Atopic dermatitis (AD) or atopic eczema (AE) is a multifactorial skin disease caused by a variety of factors such as genetic conditions, alterated skin structure, immunologic deviations and environmental factors, among others. According to the new WAO nomenclature, the term "eczema" should be used as the "umbrella" term to cover all different subtypes of atopic dermatitis, i.e. the IgE-associated ("atopic eczema") and the non-IgE-associated type ("non-atopic eczema"). Besides some comments on the new nomenclature and the so-called "atopy march", we provide an overview of the diagnostic importance of atopy patch tests, especially in the formerly called "intrinsic" type of AE and the role of Staphylococcus aureus-enterotoxins with superantigenic activity, and of fungi (Coprinus comatus and Malassezia furfur sive sympodialis) as illness-specific allergens in AD/AE. The use of antiinfectious and antifungal drugs (topic or systemic) may be of notable benefit in some AD/AE patients. Especially in children with AD/AE, eczema is easily aggravated by contact with irritating factors (e.g. aggressive detergents, synthetic and woolen clothes). Also, skin colonization with Staphylococcus aureus is known as a major trigger of the disease. Silver-coated textiles and a silk fabric coated with AEGIS AEM 5772/5, an antimicrobial substance, efficiently reduce Staphylococcus aureus colonization in patients with AD/AE. Some new studies even have shown a superior improvement by treatment with silver-coated textiles or specially manufactured silk clothes compared to cotton textiles or mild topical corticosteroids. Finally, the development of a new class of steroid-free, topic immunomodulatory drugs (tacrolimus and pimecrolimus) has substantially improved the treatment of AD/AE. Nevertheless, patient education is still very important in the management of the disease since it often follows an unpredictable course.